Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hengrui Liu

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Nature Communications|January 3, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screeningHengrui Liu, Arie Zask, Farhad Forouhar, et al.
Life Science Alliance|October 27, 2023
APR-246 increases tumor antigenicity independent of p53Judith Michels, Divya Venkatesh, Cailian Liu, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
A simplified cell-based assay to identify coronavirus 3CL protease inhibitorsSamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Molecules (Basel, Switzerland)|March 13, 2024
1,3,6-Trigalloylglucose: A Novel Potent Anti-<i>Helicobacter pylori</i> Adhesion Agent Derived from Aqueous Extracts of <i>Terminalia chebula</i> RetzLing Ou, Zhixiang Zhu, Yajie Hao, et al.
Nature Communications|March 17, 2026
Biosynthesis of pyomelanin from methanol with engineered Komagataella phaffii and its characterizationsXiangyu Zhu, Jiawen Lin, Shuli Liang, et al.
Journal of Virology|April 29, 2021
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated CytotoxicitySamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Molecular Systems Biology|January 6, 2025
A multiplex method for rapidly identifying viral protease inhibitorsSeo Jung Hong, Samuel J Resnick, Sho Iketani, et al.
Nature Chemical Biology|April 4, 2018
FINO<sub>2</sub> initiates ferroptosis through GPX4 inactivation and iron oxidationMichael M Gaschler, Alexander A Andia, Hengrui Liu, et al.
Nature Communications|April 8, 2022
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Nature Communications|January 3, 2025
Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screeningHengrui Liu, Arie Zask, Farhad Forouhar, et al.
Life Science Alliance|October 27, 2023
APR-246 increases tumor antigenicity independent of p53Judith Michels, Divya Venkatesh, Cailian Liu, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
A simplified cell-based assay to identify coronavirus 3CL protease inhibitorsSamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Molecules (Basel, Switzerland)|March 13, 2024
1,3,6-Trigalloylglucose: A Novel Potent Anti-<i>Helicobacter pylori</i> Adhesion Agent Derived from Aqueous Extracts of <i>Terminalia chebula</i> RetzLing Ou, Zhixiang Zhu, Yajie Hao, et al.
Nature Communications|March 17, 2026
Biosynthesis of pyomelanin from methanol with engineered Komagataella phaffii and its characterizationsXiangyu Zhu, Jiawen Lin, Shuli Liang, et al.
Journal of Virology|April 29, 2021
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated CytotoxicitySamuel J Resnick, Sho Iketani, Seo Jung Hong, et al.
Molecular Systems Biology|January 6, 2025
A multiplex method for rapidly identifying viral protease inhibitorsSeo Jung Hong, Samuel J Resnick, Sho Iketani, et al.
Nature Chemical Biology|April 4, 2018
FINO<sub>2</sub> initiates ferroptosis through GPX4 inactivation and iron oxidationMichael M Gaschler, Alexander A Andia, Hengrui Liu, et al.
Nature Communications|April 8, 2022
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.
Pageof 9